Howard Lazarus - Chief Medical Officer at Avalyn Pharma Inc.

Issuer-level insider activity

Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

Past-year transaction volume for Howard Lazarus in Avalyn Pharma Inc.

Buys

Open market
Shares
Avg price
Total value

Sells

Open market
Shares
-13,300
Avg price
$27.90
Total value
-$371,027

Net

Past year
Shares
-13,300
Share %
-100%
Total value
-$371,027

Reported holdings for Howard Lazarus in Avalyn Pharma Inc.

Form 4 holding Chief Medical Officer

Avalyn Pharma Inc.

Security class
Stock Option (Right to Buy)
Shares / value
257,198
Estimated value
Report date
17 Nov 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Howard Lazarus in Avalyn Pharma Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .